Theravance Biopharma Inc (TBPH)
9.14
-0.03
(-0.33%)
USD |
NASDAQ |
Apr 25, 16:00
9.16
+0.02
(+0.22%)
After-Hours: 20:00
Theravance Biopharma Market Cap: 440.23M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 25, 2024 | 440.23M |
April 24, 2024 | 441.67M |
April 23, 2024 | 444.08M |
April 22, 2024 | 455.64M |
April 19, 2024 | 449.86M |
April 18, 2024 | 443.12M |
April 17, 2024 | 458.53M |
April 16, 2024 | 466.72M |
April 15, 2024 | 477.79M |
April 12, 2024 | 462.86M |
April 11, 2024 | 430.11M |
April 10, 2024 | 459.49M |
April 09, 2024 | 456.60M |
April 08, 2024 | 456.12M |
April 05, 2024 | 448.41M |
April 04, 2024 | 440.23M |
April 03, 2024 | 447.45M |
April 02, 2024 | 438.30M |
April 01, 2024 | 434.93M |
March 28, 2024 | 432.04M |
March 27, 2024 | 433.96M |
March 26, 2024 | 424.81M |
March 25, 2024 | 421.92M |
March 22, 2024 | 429.63M |
March 21, 2024 | 431.56M |
Date | Value |
---|---|
March 20, 2024 | 433.96M |
March 19, 2024 | 426.26M |
March 18, 2024 | 416.62M |
March 15, 2024 | 416.14M |
March 14, 2024 | 414.70M |
March 13, 2024 | 423.85M |
March 12, 2024 | 410.36M |
March 11, 2024 | 412.77M |
March 08, 2024 | 415.18M |
March 07, 2024 | 418.55M |
March 06, 2024 | 420.96M |
March 05, 2024 | 417.59M |
March 04, 2024 | 438.30M |
March 01, 2024 | 454.67M |
February 29, 2024 | 456.12M |
February 28, 2024 | 452.75M |
February 27, 2024 | 466.72M |
February 26, 2024 | 444.56M |
February 23, 2024 | 432.52M |
February 22, 2024 | 417.19M |
February 21, 2024 | 421.28M |
February 20, 2024 | 428.97M |
February 16, 2024 | 423.20M |
February 15, 2024 | 416.95M |
February 14, 2024 | 406.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
395.31M
Minimum
Feb 08 2024
1.934B
Maximum
Apr 29 2020
908.01M
Average
758.53M
Median
Apr 13 2022
Market Cap Benchmarks
Corcept Therapeutics Inc | 2.299B |
Nektar Therapeutics | 242.38M |
Vanda Pharmaceuticals Inc | 257.77M |
Fate Therapeutics Inc | 384.05M |
FibroGen Inc | 100.75M |
Market Cap Related Metrics
PS Ratio | 8.807 |
Price to Book Value | 2.067 |
Price | 9.14 |
Earnings Yield | -10.61% |